FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2815-2817 December 29, 2005 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Wang, X. PubMed Citation

To the Editor: Wang et al. (Sept. 22 issue)¹ constructed a 22-phage-peptide detector for prostate cancer, with 81.6 percent sensitivity and 88.2 percent specificity. Previously, we constructed a decision tree for classifying prostate cancer, using five tumor-associated antigens, with 79 percent sensitivity and 86 percent specificity.² With a smaller panel, these rates are equivalent to those of Wang et al. and might be improved by the selection of other tumor-associated antigens.

Only four peptides in the panel that was developed by Wang et al. were derived from in-frame coding sequences. Whether the other 18 peptides are mimotopes could be determined, . . . [Full Text of this Article]

This article has been cited by other articles:

• Casiano, C. A., Mediavilla-Varela, M., Tan, E. M. (2006). Tumor-associated Antigen Arrays for the Serological Diagnosis of Cancer. Mol. Cell. Proteomics 5: 1745-1759 [Abstract] [Full Text]